For: | Low G, Huang G, Fu W, Moloo Z, Girgis S. Review of renal cell carcinoma and its common subtypes in radiology. World J Radiol 2016; 8(5): 484-500 [PMID: 27247714 DOI: 10.4329/wjr.v8.i5.484] |
---|---|
URL: | https://www.wjgnet.com/1949-8470/full/v8/i5/484.htm |
Number | Citing Articles |
1 |
Amar Udare, Daniel Walker, Satheesh Krishna, Robert Chatelain, Matthew DF McInnes, Trevor A Flood, Nicola Schieda. Characterization of clear cell renal cell carcinoma and other renal tumors: evaluation of dual-energy CT using material-specific iodine and fat imaging. European Radiology 2020; 30(4): 2091 doi: 10.1007/s00330-019-06590-1
|
2 |
Nicholas J. Vogelzang, Mark R. Olsen, Joshua J. McFarlane, Edward Arrowsmith, Todd M. Bauer, Rohit K. Jain, Bradley Somer, Elaine T. Lam, Mark D. Kochenderfer, Ana Molina, Gurjyot Doshi, Brian Lingerfelt, Ralph J. Hauke, Vijay Gunuganti, Ian Schnadig, Peter Van Veldhuizen, Mark Fleming, Robert Galamaga, Mukul Gupta, Hugo Hool, Thomas Hutson, Joshua Zhang, M. Brent McHenry, Jennifer L. Johansen, Scott S. Tykodi. Safety and Efficacy of Nivolumab in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study. Clinical Genitourinary Cancer 2020; 18(6): 461 doi: 10.1016/j.clgc.2020.05.006
|
3 |
Naoki Toda, Masahiro Hashimoto, Yuki Arita, Hasnine Haque, Hirotaka Akita, Toshiaki Akashi, Hideo Gobara, Akihiro Nishie, Masahiro Yakami, Atsushi Nakamoto, Takeyuki Watadani, Mototsugu Oya, Masahiro Jinzaki. Deep Learning Algorithm for Fully Automated Detection of Small (≤4 cm) Renal Cell Carcinoma in Contrast-Enhanced Computed Tomography Using a Multicenter Database. Investigative Radiology 2022; 57(5): 327 doi: 10.1097/RLI.0000000000000842
|
4 |
Jonathan Lyske, Rishi Philip Mathew, Christopher Hutchinson, Vimal Patel, Gavin Low. Multimodality imaging review of focal renal lesions. Egyptian Journal of Radiology and Nuclear Medicine 2021; 52(1) doi: 10.1186/s43055-020-00391-z
|
5 |
蓉 徐. The Role of the Active Ingredients in Tea in Delaying the Progression of Chronic Kidney Disease. Advances in Clinical Medicine 2024; 14(04): 1719 doi: 10.12677/acm.2024.1441216
|
6 |
Magdalena Rudzinska, Karolina H. Czarnecka-Chrebelska, Ekaterina B. Kuznetsova, Sofya V. Maryanchik, Alessandro Parodi, Dmitry O. Korolev, Nataliya Potoldykova, Yulia Svetikova, Andrey Z. Vinarov, Marina V. Nemtsova, Andrey A. Zamyatnin. Long Non-Coding PROX1-AS1 Expression Correlates with Renal Cell Carcinoma Metastasis and Aggressiveness. Non-Coding RNA 2021; 7(2): 25 doi: 10.3390/ncrna7020025
|
7 |
Priyanka Jha, Mallika Shekhar, Jennifer Wan, Carina Mari-Aparici. Diffuse thyroid metastases and bilateral internal jugular vein tumor thrombus from renal cell cancer. Radiology Case Reports 2016; 11(4): 434 doi: 10.1016/j.radcr.2016.08.016
|
8 |
Jie Liu, Shufang Yang, Haiying Jin, Xiang He, Peng Nie, Changfu Wang. The diagnostic value of multi-slice spiral computed tomography in patients with renal carcinoma. Journal of Cancer Research and Therapeutics 2018; 14(4): 795 doi: 10.4103/jcrt.JCRT_582_17
|
9 |
Medhat Ibraheem Mohammad Ahmad, Mohammad Sabr, Eman Roshy. Assessment of apparent diffusion coefficient value as prognostic factor for renal cell carcinoma aggressiveness. Egyptian Journal of Radiology and Nuclear Medicine 2019; 50(1) doi: 10.1186/s43055-019-0038-3
|
10 |
Jiefu Tang, Fan Yao, Zhiyong Yao, Xiao-Liang Xing. Characterization of tumor microenvironment and sensitive chemotherapy drugs based on cuproptosis-related signatures in renal cell carcinoma. Aging 2023; 15(18): 9695 doi: 10.18632/aging.205043
|
11 |
Baek Gyu Jun. Diagnosis of Renal Mass on Ultrasonography. Clinical Ultrasound 2018; 3(2): 50 doi: 10.18525/cu.2018.3.2.50
|
12 |
James J. Hsieh, Mark P. Purdue, Sabina Signoretti, Charles Swanton, Laurence Albiges, Manuela Schmidinger, Daniel Y. Heng, James Larkin, Vincenzo Ficarra. Renal cell carcinoma. Nature Reviews Disease Primers 2017; 3(1) doi: 10.1038/nrdp.2017.9
|
13 |
Ali Morshid, Elif S Duran, Woongsoon J Choi, Cihan Duran. A Concise Review of the Multimodality Imaging Features of Renal Cell Carcinoma. Cureus 2021; doi: 10.7759/cureus.13231
|
14 |
|
15 |
M.Á. Corral de la Calle, J. Encinas de la Iglesia, M.R. Martín López, G.C. Fernández Pérez, D.S. Águeda del Bas. The radiologist's role in the management of papillary renal cell carcinoma. Radiología (English Edition) 2017; 59(2): 100 doi: 10.1016/j.rxeng.2017.03.001
|
16 |
Chandan J Das, Ankita Aggarwal, Prabhjot Singh, B Nayak, Taruna Yadav, Anupam Lal, Ujjwal Gorsi, Atul Batra, Shamim Ahmed Shamim, Bijit Kumar Duara, Kevin Arulraj, Seema Kaushal, Amlesh Seth. Imaging Recommendations for Diagnosis, Staging, and Management of Renal Tumors. Indian Journal of Medical and Paediatric Oncology 2023; 44(01): 084 doi: 10.1055/s-0042-1759718
|
17 |
Nadeem ur Rahman, Hemanth Neeli, Ayush Gupta, Jitendra Sharma, Pratik Minj. Venous Tropism in Renal Cell Carcinoma: A Rare Imaging Presentation. Cureus 2024; doi: 10.7759/cureus.70927
|
18 |
|
19 |
Ji‑Hoon Jang, In‑Hwan Song, Eon‑Gi Sung, Tae‑Jin Lee, Joo‑Young Kim. Metformin‑induced apoptosis facilitates degradation of the cellular caspase 8 (FLICE)‑like inhibitory protein through a caspase‑dependent pathway in human renal cell carcinoma A498 cells. Oncology Letters 2018; doi: 10.3892/ol.2018.8832
|
20 |
Elisa Scalco, Silvia Pozzi, Giovanna Rizzo, Ettore Lanzarone. Uncertainty quantification in multi‐class segmentation: Comparison between Bayesian and non‐Bayesian approaches in a clinical perspective. Medical Physics 2024; 51(9): 6090 doi: 10.1002/mp.17189
|
21 |
Masato Yanagi, Tomonari Kiriyama, Jun Akatsuka, Yuki Endo, Yuka Toyama, Go Kimura, Taiji Nishimura, Yukihiro Kondo. Role of collateral vessels on contrast-enhanced computed tomography in predicting metastatic potential for small renal cell carcinoma. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01409-y
|
22 |
Jianbo Zheng, Yanhui Mei, Ping Xiang, Guangsheng Zhai, Ning Zhao, Chuanbing Xu, Min Liu, Zhengsheng Pan, Kai Tang, Dongsheng Jia. DNA methylation affects metastasis of renal cancer and is associated with TGF-β/RUNX3 inhibition. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0554-7
|
23 |
Magdalena Chrabańska, Magdalena Rynkiewicz, Paweł Kiczmer, Bogna Drozdzowska. Immunohistochemical Expression of CD44, MMP-2, MMP-9, and Ki-67 as the Prognostic Markers in Non-Clear Cell Renal Cell Carcinomas—A Prospective Cohort Study. Journal of Clinical Medicine 2022; 11(17): 5196 doi: 10.3390/jcm11175196
|
24 |
Jing Ji, Yuxin Xu, Mengru Xie, Xingbei He, Dexu Ren, Teng Qiu, Wenwen Liu, Zefeng Chen, Wen Shi, Zhen Zhang, Xiujun Wang, Weiling Wang, Jinming Ma, Qilan Qian, Aixin Jing, Xinhui Ma, Jingting Qin, Yuanyuan Ding, Ting Geng, Jiayan Yang, Zhichao Sun, Wei Liu, Shunfang Liu, Bin Liu. VHL-HIF-2α axis-induced SEMA6A upregulation stabilized β-catenin to drive clear cell renal cell carcinoma progression. Cell Death & Disease 2023; 14(2) doi: 10.1038/s41419-023-05588-4
|
25 |
Yao-Jie Pan, Lu-Lu Wei, Xiao-Jin Wu, Fu-Chun Huo, Jie Mou, Dong-Sheng Pei. MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5. Cell Death & Disease 2017; 8(10): e3155 doi: 10.1038/cddis.2017.561
|
26 |
Abhijit Sreepada, Mansi Tiwari, Kasturi Pal. Adhesion G protein-coupled receptor gluing action guides tissue development and disease. Journal of Molecular Medicine 2022; 100(10): 1355 doi: 10.1007/s00109-022-02240-0
|
27 |
Nadine Gelbrich, Hannes Ahrend, Anne Kaul, Lars-Ove Brandenburg, Uwe Zimmermann, Alexander Mustea, Martin Burchardt, Denis Gümbel, Matthias B. Stope. Different Cytokine and Chemokine Expression Patterns in Malignant Compared to Those in Nonmalignant Renal Cells. Analytical Cellular Pathology 2017; 2017: 1 doi: 10.1155/2017/7190546
|
28 |
Jincey D. Sriram, Irma van de Beek, Paul C. Johannesma, Michiel H. van Werkum, Tijmen J. W. T. van der Wel, Elise M. Wessels, Hans J. J. P. Gille, Arjan C. Houweling, Pieter E. Postmus, Hans J. M. Smit. Birt-Hogg-Dubé syndrome in apparent primary spontaneous pneumothorax patients; results and recommendations for clinical practice. BMC Pulmonary Medicine 2022; 22(1) doi: 10.1186/s12890-022-02107-7
|
29 |
MO Nalbant, E Inci. Assessment of Imaging Findings of Renal Carcinoma Subtypes with 3.0T MRI. Nigerian Journal of Clinical Practice 2023; 26(11): 1750 doi: 10.4103/njcp.njcp_373_23
|
30 |
Fan Yang, Zi-Chen Zhao, A-Jin Hu, Peng-Fei Sun, Bin Zhang, Ming-Chuan Yu, Juan Wang. Synchronous sporadic bilateral multiple chromophobe renal cell carcinoma accompanied by a clear cell carcinoma and a cyst: A case report. World Journal of Clinical Cases 2020; 8(14): 3064-3073 doi: 10.12998/wjcc.v8.i14.3064
|
31 |
Rui Wang, Junying Zheng, Xiao Shao, Yuko Ishii, Amit Roy, Akintunde Bello, Richard Lee, Joshua Zhang, Megan Wind-Rotolo, Yan Feng. Development of a prognostic composite cytokine signature based on the correlation with nivolumab clearance: translational PK/PD analysis in patients with renal cell carcinoma. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0819-2
|
32 |
Chongfeng Duan, Nan Li, Lei Niu, Gang Wang, Jiping Zhao, Fang Liu, Xuejun Liu, Yande Ren, Xiaoming Zhou. CT texture analysis for the differentiation of papillary renal cell carcinoma subtypes. Abdominal Radiology 2020; 45(11): 3860 doi: 10.1007/s00261-020-02588-2
|
33 |
Michael T. Corwin, Emre Altinmakas, Daniella Asch, Kristen A. Bishop, Medine Boge, Nicole E. Curci, Mohamed Ebada, Asser Abou Elkassem, Ghaneh Fananapazir, David T. Fetzer, Ayman H. Gaballah, Darshan Gandhi, Rony Kampalath, Sonia Lee, Matt Markese, Matthew D. F. McInnes, Nayana U. Patel, Erick M. Remer, Sarah Rosasco, Nicola Schieda, David E. Sweet, Andrew D. Smith, Erin Taylor, Stuart G. Silverman, Matthew S. Davenport. Clinical Importance of Incidental Homogeneous Renal Masses That Measure 10–40 mm and 21–39 HU at Portal Venous Phase CT: A 12-Institution Retrospective Cohort Study. American Journal of Roentgenology 2021; 217(1): 135 doi: 10.2214/AJR.20.24245
|
34 |
Hari K. Rachamala, Vijay S. Madamsetty, Ramcharan S. Angom, Naga M. Nakka, Shamit Kumar Dutta, Enfeng Wang, Debabrata Mukhopadhyay, Krishnendu Pal. Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-024-03079-8
|
35 |
Jacob J. Adashek, Yumeng Zhang, William Paul Skelton, Alyssa Bilotta, Jad Chahoud, Logan Zemp, Jiannong Li, Jasreman Dhillon, Brandon Manley, Philippe E. Spiess. Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.627025
|
36 |
Camila Lopes Vendrami, Robert J. McCarthy, Carolina Parada Villavicencio, Frank H. Miller. Predicting common solid renal tumors using machine learning models of classification of radiologist-assessed magnetic resonance characteristics. Abdominal Radiology 2020; 45(9): 2797 doi: 10.1007/s00261-020-02637-w
|
37 |
Kathy Liu, Mario Russo, Joshua S. Ellis, John Di Capua, Dufan Wu, Sara Smolinski‐Zhao, Sanjeeva Kalva, Ronald S. Arellano, Zubin Irani, Raul Uppot, Stephen W. Linderman, Rajiv Gupta, Joanna Aizenberg, Shriya Srinivasan, Avik Som. Transient, Image‐Guided Gel‐Dissection for Percutaneous Thermal Ablation. Advanced Healthcare Materials 2024; doi: 10.1002/adhm.202400272
|
38 |
Young Yun Jung, Seung Ho Baek, Jae-Young Um, Kwang Seok Ahn. Fangchinoline targets human renal cell carcinoma cells through modulation of apoptotic and non‑apoptotic cell deaths. Pathology - Research and Practice 2024; 260: 155445 doi: 10.1016/j.prp.2024.155445
|
39 |
Mahmoud S. Soliman, Afrasim Moin, Talib Hussain, D.V. Gowda, Sheshagiri R. Dixit, Amr S. Abu Lila. Development and optimization of dual drug-loaded nanoparticles for the potent anticancer effect on renal carcinoma. Journal of Drug Delivery Science and Technology 2020; 59: 101846 doi: 10.1016/j.jddst.2020.101846
|
40 |
Naveenjyote S. Boora, Perlau Michaela, Christopher I. Fung. Renal Cell Carcinoma Subtypes and Associated Renal Malignancies: A Pictorial Review—Part I. Contemporary Diagnostic Radiology 2022; 45(3): 1 doi: 10.1097/01.CDR.0000820620.95153.1e
|
41 |
Silvia Vidali, Sepideh Aminzadeh-Gohari, René Günther Feichtinger, Renaud Vatrinet, Andreas Koller, Felix Locker, Tricia Rutherford, Maura O’Donnell, Andrea Stöger-Kleiber, Bridget Lambert, Thomas Klaus Felder, Wolfgang Sperl, Barbara Kofler. The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome. Oncotarget 2017; 8(34): 57201 doi: 10.18632/oncotarget.19306
|
42 |
Amira R. Mahmoud, Nehad Fouda, Eman Mohamed Helmy, Ali Elsorougy. Role of intravoxel incoherent motion diffusion-weighted MRI in differentiation of renal cell carcinoma subtypes. Egyptian Journal of Radiology and Nuclear Medicine 2024; 55(1) doi: 10.1186/s43055-024-01352-6
|
43 |
Jiangke Tian, Tao Xu, Lijun Fan, Haiou Sun. Value of Contrast‐Enhanced Ultrasound in the Diagnosis of Clear Cell Renal Cell Carcinoma: A Meta‐Analysis. Journal of Clinical Ultrasound 2024; doi: 10.1002/jcu.23861
|
44 |
Camila Lopes Vendrami, Yuri S. Velichko, Frank H. Miller, Argha Chatterjee, Carolina Parada Villavicencio, Vahid Yaghmai, Robert J. McCarthy. Differentiation of Papillary Renal Cell Carcinoma Subtypes on MRI: Qualitative and Texture Analysis. American Journal of Roentgenology 2018; 211(6): 1234 doi: 10.2214/AJR.17.19213
|
45 |
Sylvain Bodard, Christophe Delavaud, Charles Dariane, Idris Boudhabhay, Nour El Imane Bensenouci, Marc-Olivier Timsit, Jean-Michel Correas, Virginie Verkarre, Olivier Hélénon. Low-grade oncocytic tumor of the kidney: imaging features of a novel tumor entity. Abdominal Radiology 2024; 49(12): 4307 doi: 10.1007/s00261-024-04487-2
|
46 |
Simone O. Heyliger, Karam F. A. Soliman, Marilyn D. Saulsbury, Romonia Renee Reams. The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma. Biomolecules 2021; 11(8): 1193 doi: 10.3390/biom11081193
|
47 |
Alessio Rizzo, Manuela Racca, Sara Dall’Armellina, Pasquale Rescigno, Giuseppe Luigi Banna, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia. The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. Cancers 2023; 15(2): 355 doi: 10.3390/cancers15020355
|
48 |
Pia Iben Pietersen, Janni Lynggård Bo Madsen, Jon Asmussen, Lars Lund, Tommy Kjærgaard Nielsen, Michael Pedersen, Birte Engvad, Ole Graumann. Multiparametric magnetic resonance imaging for characterizing renal tumors: A validation study of the algorithm presented by Cornelis et al.. Journal of Clinical Imaging Science 2023; 13: 7 doi: 10.25259/JCIS_124_2022
|
49 |
Michael Ladurner, Andrea Katharina Lindner, Peter Rehder, Gennadi Tulchiner. The influence of sex hormones on renal cell carcinoma. Therapeutic Advances in Medical Oncology 2024; 16 doi: 10.1177/17588359241269664
|
50 |
Mohamed Shehata, Ahmed Elmahdy, Ahmed Alksas, Rasha Abouelkheir, Ali Mahmoud, Mohamed Abou El-Ghar, Mohammed Ghazal, Ayman S. El-Baz. State of the Art in Neural Networks and Their Applications. 2023; : 235 doi: 10.1016/B978-0-12-819872-8.00018-5
|
51 |
Brindley David Cupido, Medica Sam, Sean David Winters, Bilal Ahmed, Michael Seidler, Guan Huang, Gavin Low. A practical imaging classification for the non-invasive differentiation of renal cell carcinoma into its main subtypes. Abdominal Radiology 2017; 42(3): 908 doi: 10.1007/s00261-016-0940-3
|
52 |
Heidi Coy, Jonathan R. Young, Michael L. Douek, Matthew S. Brown, James Sayre, Steven S. Raman. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography. Abdominal Radiology 2017; 42(7): 1919 doi: 10.1007/s00261-017-1095-6
|
53 |
Xiangjun Shu, Zaiqi Zhang, Zhi-Yong Yao, Xiao-Liang Xing. Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer. Frontiers in Molecular Biosciences 2022; 8 doi: 10.3389/fmolb.2021.763697
|
54 |
Goran Mitreski, Tom Sutherland. Radiological diagnosis of perinephric pathology: pictorial essay 2015. Insights into Imaging 2017; 8(1): 155 doi: 10.1007/s13244-016-0536-z
|
55 |
Yuwan Zhao, Xinghua Lin, Wenfeng Zeng, Xingzhang Qin, Bailiang Miao, Sheng Gao, Jianjun Liu, Zhuo Li. Berberine inhibits the progression of renal cell carcinoma cells by regulating reactive oxygen species generation and inducing DNA damage. Molecular Biology Reports 2023; 50(7): 5697 doi: 10.1007/s11033-023-08381-w
|
56 |
Francesco Trevisani, Matteo Floris, Roberto Minnei, Alessandra Cinque. Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer. International Journal of Molecular Sciences 2022; 23(5): 2603 doi: 10.3390/ijms23052603
|
57 |
Takashi Tsuyukubo, Kazuyuki Ishida, Mitsumasa Osakabe, Ei Shiomi, Renpei Kato, Ryo Takata, Wataru Obara, Tamotsu Sugai. Comprehensive analysis of somatic copy number alterations in clear cell renal cell carcinoma. Molecular Carcinogenesis 2020; 59(4): 412 doi: 10.1002/mc.23164
|
58 |
Sandeep Bhoriwal, Kunal Dhall, Adarsh Barwad, Ashutosh Mishra. Renal cell carcinoma arising in an open pyelolithotomy scar: A perplexing scenario!. Journal of Current Oncology 2020; 3(2): 93 doi: 10.4103/jco.jco_26_20
|
59 |
Salvador Cazorla-Vázquez, Felix B. Engel. Adhesion GPCRs in Kidney Development and Disease. Frontiers in Cell and Developmental Biology 2018; 6 doi: 10.3389/fcell.2018.00009
|
60 |
Nicola Schieda, Robert S. Lim, Satheesh Krishna, Matthew D. F. McInnes, Trevor A. Flood, Rebecca E. Thornhill. Diagnostic Accuracy of Unenhanced CT Analysis to Differentiate Low-Grade From High-Grade Chromophobe Renal Cell Carcinoma. American Journal of Roentgenology 2018; 210(5): 1079 doi: 10.2214/AJR.17.18874
|
61 |
Ahmet Mesrur Halefoglu, Ayse Aysim Ozagari. Comparison of cortico-medullary phase contrast-enhanced MDCT and T2-weighted MR imaging in the histological subtype differentiation of renal cell carcinoma : radiology-pathology correlation. Polish Journal of Radiology 2021; 86: 583 doi: 10.5114/pjr.2021.111013
|
62 |
Vincenzo Ficarra, Simona Caloggero, Marta Rossanese, Silvio Mazziotti, Giuseppe Mucciardi, Giuseppe Cicero, Giuseppina Anastasi, Giorgio Ascenti. Renal Cancer. 2022; : 35 doi: 10.1007/978-3-030-84756-2_4
|
63 |
Sunwoo Park. Renal Oncocytoma Presenting as a Huge Hypervascular Mass on Ultrasound. Clinical Ultrasound 2022; 7(2): 114 doi: 10.18525/cu.2022.7.2.114
|
64 |
Lejla Aganovic, Dominik Nörenberg. Diseases of the Abdomen and Pelvis 2023-2026. IDKD Springer Series 2023; : 153 doi: 10.1007/978-3-031-27355-1_11
|
65 |
|
66 |
Mohammad Al-Zubi, Khayry Al-Shami, Leen Sawalha, Heyam Alguzo, Saddam Al Demour, Asma’a Al-Mnayyis, Rami Alazab, Samer Al-Rawashdah, Lana Alzoubi, Sawsan Al-khawaldeh. Can We Predict the Grade of Clear Cell Renal Cell Carcinoma from Houns-Field Unit of Renal Lesion on Computerized Tomography Scan, a Retrospective Cross-Sectional Study. International Journal of General Medicine 2024; : 1571 doi: 10.2147/IJGM.S452754
|
67 |
Richard G. Barr, Stephanie R. Wilson, Andrej Lyshchik, Beth McCarville, Kassa Darge, Edward Grant, Michelle Robbin, Juergen Karl Wilmann, Wui K. Chong, Arthur Fleischer, Harriet J. Paltiel. Contrast-enhanced Ultrasound—State of the Art in North America. Ultrasound Quarterly 2020; 36(4S): S1 doi: 10.1097/RUQ.0000000000000515
|
68 |
Monika Gudowska-Sawczuk, Jacek Kudelski, Barbara Mroczko. The Role of Chemokine Receptor CXCR3 and Its Ligands in Renal Cell Carcinoma. International Journal of Molecular Sciences 2020; 21(22): 8582 doi: 10.3390/ijms21228582
|
69 |
Andrea Coppola, Luigi Tessitore, Federico Fontana, Filippo Piacentino, Chiara Recaldini, Manuela Minenna, Paolo Capogrosso, Roberto Minici, Domenico Laganà, Anna Maria Ierardi, Gianpaolo Carrafiello, Fabio D’Angelo, Giulio Carcano, Laura Maria Cacioppa, Federico Dehò, Massimo Venturini. Dual-Energy Computed Tomography in Urological Diseases: A Narrative Review. Journal of Clinical Medicine 2024; 13(14): 4069 doi: 10.3390/jcm13144069
|
70 |
Silvio Mazziotti, Giuseppe Cicero, Tommaso D’Angelo, Maria Adele Marino, Carmela Visalli, Ignazio Salamone, Giorgio Ascenti, Alfredo Blandino. Imaging and Management of Incidental Renal Lesions. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/1854027
|
71 |
Zhang, MD Qing, Wei, MD Shuping, Yang, MD Bin, Qian, MD Xiaoqin. Differences Between Type I and Type II Papillary Renal Cell Carcinoma on Ultrasound. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY 2019; 3(4): 187 doi: 10.37015/AUDT.2019.191220
|
72 |
D Talaat, F Zada, R Kadry. Staging of clear cell renal cell carcinoma using random forest and support vector machine. Journal of Physics: Conference Series 2020; 1447(1): 012012 doi: 10.1088/1742-6596/1447/1/012012
|
73 |
Rattiyaporn Kanlaya, Visith Thongboonkerd. Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases. Advances in Nutrition 2019; 10(1): 112 doi: 10.1093/advances/nmy077
|
74 |
Dan Wang, Xiaoyu Huang, Liangcai Bai, Xueling Zhang, Jinyan Wei, Junlin Zhou. Differential diagnosis of chromophobe renal cell carcinoma and papillary renal cell carcinoma with dual-energy spectral computed tomography. Acta Radiologica 2020; 61(11): 1562 doi: 10.1177/0284185120903447
|
75 |
Masato Yanagi, Tomonari Kiriyama, Jun Akatsuka, Yuki Endo, Hayato Takeda, Akifumi Katsu, Yuichiro Honda, Kyota Suzuki, Yoshihiro Nishikawa, Shunsuke Ikuma, Hikaru Mikami, Yuka Toyama, Go Kimura, Yukihiro Kondo. Differential diagnosis and prognosis of small renal masses: association with collateral vessels detected using contrast-enhanced computed tomography. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09971-w
|
76 |
Hamideh Ale Ali, Marcus J. Couch, Ravi Menezes, Andrew J. Evans, Antonio Finelli, Michael A. Jewett, Kartik S. Jhaveri. Predictive Value of In Vivo MR Spectroscopy With Semilocalization by Adiabatic Selective Refocusing in Differentiating Clear Cell Renal Cell Carcinoma From Other Subtypes. American Journal of Roentgenology 2020; 214(4): 817 doi: 10.2214/AJR.19.22023
|
77 |
Vineeth M. Thirunavu, Anastasios Roumeliotis, Nathan A. Shlobin, Viswajit Kandula, Parth Shah, Collin Larkin, Kyle Chan, Benjamin S. Hopkins, Michael Cloney, Constantine L. Karras, Nader S. Dahdaleh. The role of preoperative embolization in the treatment of spinal metastases from renal cell carcinoma. Clinical Neurology and Neurosurgery 2022; 215: 107181 doi: 10.1016/j.clineuro.2022.107181
|
78 |
Xiongmin Mao, Guanyi Wang, Zijian Wang, Chen Duan, Xiaoliang Wu, Hua Xu. Theranostic Lipid Nanoparticles for Renal Cell Carcinoma. Advanced Materials 2023; doi: 10.1002/adma.202306246
|
79 |
Nicolò Gennaro, Riccardo Muglia, Fabrizia Gelardi, Francesca Piccoli, Arturo Chiti. Multimodality Imaging and Intervention in Oncology. 2023; : 273 doi: 10.1007/978-3-031-28524-0_14
|
80 |
Xuan-Yin Chen, Min Lan, Yang Zhou, Wen-Zhao Chen, Dong Hu, Jia-Ming Liu, Shan-Hu Huang, Zhi-Li Liu, Zhi-Hong Zhang. Risk factors for bone metastasis from renal cell cancer. Journal of Bone Oncology 2017; 9: 29 doi: 10.1016/j.jbo.2017.10.004
|
81 |
Michael T. Corwin, Shan S. Hansra, Thomas W. Loehfelm, Ramit Lamba, Ghaneh Fananapazir. Prevalence of Solid Tumors in Incidentally Detected Homogeneous Renal Masses Measuring > 20 HU on Portal Venous Phase CT. American Journal of Roentgenology 2018; 211(3): W173 doi: 10.2214/AJR.17.19351
|
82 |
Cynthia Dawes. Chromophobe renal cell carcinoma: An unexpected finding in a pelvic ultrasound. Sonography 2022; 9(2): 92 doi: 10.1002/sono.12301
|
83 |
Richard G. Barr, Stephanie R. Wilson, Andrej Lyshchik, Beth McCarville, Kassa Darge, Edward Grant, Michelle Robbin, Juergen Karl Wilmann, Wui K. Chong, Arthur Fleischer, Harriet J. Paltiel. Contrast -Enhanced Ultrasound. Ultrasound Quarterly 2020; 36(3): 206 doi: 10.1097/RUQ.0000000000000514
|
84 |
Amal Fekkar, Kaoutar Znati, Fouad Zouaidia, Hafsa Elouazzani, Zakia Bernoussi, Ahmed Jahid, Apul Goel. Concurrent Angiomyolipoma and Clear Cell Renal Cell Carcinoma in the Same Kidney: A Rare Finding in a Patient without Tuberous Sclerosis. Case Reports in Urology 2021; 2021: 1 doi: 10.1155/2021/6663369
|
85 |
Xi-Feng Cui, Xi-Gang Cui, Ning Leng. Overexpression of interleukin-20 receptor subunit beta (IL20RB) correlates with cell proliferation, invasion and migration enhancement and poor prognosis in papillary renal cell carcinoma. Journal of Toxicologic Pathology 2019; 32(4): 245 doi: 10.1293/tox.2019-0017
|
86 |
Xiaojuan Li, Hao Li, Caihong Yang, Liu Liu, Sisi Deng, Mi Li. Comprehensive Analysis of ATP6V1s Family Members in Renal Clear Cell Carcinoma With Prognostic Values. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.567970
|
87 |
Zhigang Cheng, Xiaoling Yu, Zhiyu Han, Fangyi Liu, Jie Yu, Jian Yang, Danni Ai, Ping Liang. Percutaneous microwave ablation under ultrasound guidance for renal cell carcinomas at clinical staging T1 in patients aged 65 years and older. Journal of Cancer Research and Therapeutics 2022; 18(2): 509 doi: 10.4103/jcrt.jcrt_531_22
|
88 |
Qihua Yin, Huiting Xu, Yanqi Zhong, Jianming Ni, Shudong Hu. Diagnostic performance of MRI, SPECT, and PET in detecting renal cell carcinoma: a systematic review and meta-analysis. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09239-3
|
89 |
Zhigang Cheng, Xiaoling Yu, Zhiyu Han, Fangyi Liu, Jie Yu, Ping Liang. Ultrasound-guided hydrodissection for assisting percutaneous microwave ablation of renal cell carcinomas adjacent to intestinal tracts: a preliminary clinical study. International Journal of Hyperthermia 2018; 34(3): 315 doi: 10.1080/02656736.2017.1338362
|
90 |
Ee Jean Lim, Khi Yung Fong, Jingqiu Li, Hong Hong Huang, Kenneth Chen, Kae Jack Tay, Christopher Wai Sam Cheng, Henry Sun Sien Ho, Nye Thane Ngo, John Shyi Peng Yuen. Clinicopathological features of non-conventional renal cell carcinoma histological subtypes: Learning points from a large contemporary series spanning over three decades. Investigative and Clinical Urology 2022; 63(2): 151 doi: 10.4111/icu.20210373
|
91 |
Zhijie Xu, Yunfei Wu, Guanan Zhao, Baiye Jin, Peng Jiang. A novel DNA methylation signature revealed GDF6 and RCC1 as potential prognostic biomarkers correlated with cell proliferation in clear cell renal cell carcinoma. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-023-09003-1
|
92 |
Aisha Siddiqi, Madhu Rani, Preeti Bansal, M. Moshahid Alam Rizvi. Renal cell carcinoma management: A step to nano-chemoprevention. Life Sciences 2022; 308: 120922 doi: 10.1016/j.lfs.2022.120922
|
93 |
Andrew A. Renshaw, Alex Powell, Jorge Caso, Edwin W. Gould. Needle track seeding in renal mass biopsies. Cancer Cytopathology 2019; 127(6): 358 doi: 10.1002/cncy.22147
|
94 |
Myungjin Moon, Kenta Nakai. Integrative analysis of gene expression and DNA methylation using unsupervised feature extraction for detecting candidate cancer biomarkers. Journal of Bioinformatics and Computational Biology 2018; 16(02): 1850006 doi: 10.1142/S0219720018500063
|
95 |
Seyed Morteza Bagheri, Fatemeh Khajehasani, Iman Fatemi, Mohammad Reza Ayoubpour. Tumoral vascular pattern in renal cell carcinoma and fat-poor renal angiomyolipoma as a novel helpful differentiating factor on contrast-enhanced CT scan. Tumor Biology 2017; 39(10): 101042831773314 doi: 10.1177/1010428317733144
|
96 |
Krishnendu Pal, Vijay Sagar Madamsetty, Shamit Kumar Dutta, Enfeng Wang, Ramcharan Singh Angom, Debabrata Mukhopadhyay. Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer. npj Precision Oncology 2019; 3(1) doi: 10.1038/s41698-019-0105-2
|
97 |
Harry R. Marshall, Sepideh Shakeri, Melina Hosseiny, Anthony Sisk, James Sayre, David S. Lu, Allan Pantuck, Steven Raman. Long-Term Survival after Percutaneous Radiofrequency Ablation of Pathologically Proven Renal Cell Carcinoma in 100 Patients. Journal of Vascular and Interventional Radiology 2020; 31(1): 15 doi: 10.1016/j.jvir.2019.09.011
|
98 |
Sindhu Kumar, Mayur Virarkar, Sai Swarupa R. Vulasala, Taher Daoud, Savas Ozdemir, Carissa Wieseler, Fiorella Vincety-Latorre, Dheeraj R. Gopireddy, Priya Bhosale, Chandana Lall. Magnetic Resonance Imaging Virtual Biopsy of Common Solid Renal Masses—A Pictorial Review. Journal of Computer Assisted Tomography 2023; 47(2): 186 doi: 10.1097/RCT.0000000000001424
|
99 |
N. Schieda, R.S. Lim, M.D.F. McInnes, I. Thomassin, R. Renard-Penna, S. Tavolaro, F.H. Cornelis. Characterization of small (<4 cm) solid renal masses by computed tomography and magnetic resonance imaging: Current evidence and further development. Diagnostic and Interventional Imaging 2018; 99(7-8): 443 doi: 10.1016/j.diii.2018.03.004
|
100 |
Priyanka Kancherla, Michael Daneshvar, Rebecca A. Sager, Mehdi Mollapour, Gennady Bratslavsky. Fumarate hydratase as a therapeutic target in renal cancer. Expert Opinion on Therapeutic Targets 2020; 24(9): 923 doi: 10.1080/14728222.2020.1804862
|
101 |
Zhongjie YANG, Ming LI, Aiju GUO, Yonghui LIANG, Peng FANG. Imaging features and clinic value of mri and ct in diagnosis of clear cell renal cell carcinoma. Food Science and Technology 2022; 42 doi: 10.1590/fst.40520
|
102 |
Tongjun Gu, Xiwu Zhao. Integrating multi-platform genomic datasets for kidney renal clear cell carcinoma subtyping using stacked denoising autoencoders. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53048-x
|
103 |
Robert S. Lim, Trevor A. Flood, Matthew D. F. McInnes, Luke T. Lavallee, Nicola Schieda. Renal angiomyolipoma without visible fat: Can we make the diagnosis using CT and MRI?. European Radiology 2018; 28(2): 542 doi: 10.1007/s00330-017-4988-4
|
104 |
Xiaoqi Lin, Joseph F. Peevey, Ali Habib, Ronald Mora, Ahsun Riaz. Atlas of Cytopathology and Radiology. 2020; : 101 doi: 10.1007/978-3-030-24756-0_5
|
105 |
Nuerguli Maimaiti, Lu Wen, Xiufang Li, Lei Wang, Ayinigeer Abulimiti, Weijun Tao, Wen Jiang, Delian Zhang. Secondary Hypertension. 2020; : 125 doi: 10.1007/978-981-15-0591-1_5
|
106 |
K. Mueller-Peltzer, G. Negrao de Figueiredo, T. Graf, J. Rübenthaler, D.-A. Clevert, F. Jung, M. Fornal. Papillary renal cell carcinoma in contrast-enhanced ultrasound (CEUS) – A diagnostic performance study. Clinical Hemorheology and Microcirculation 2019; 71(2): 159 doi: 10.3233/CH-189406
|
107 |
|
108 |
M.Á. Corral de la Calle, J. Encinas de la Iglesia, M.R. Martín López, G.C. Fernández Pérez, D.S. Águeda del Bas. Carcinoma papilar de células renales: el papel del radiólogo en su manejo. Radiología 2017; 59(2): 100 doi: 10.1016/j.rx.2016.11.005
|
109 |
L Damgacı, H Özer, G Rona. Diagnostic Value of MDCT in Determining the Perinephric Fat Tissue and Renal Sinus Invasion in Patients with Clear Cell Renal Cell Carcinoma. Nigerian Journal of Clinical Practice 2021; 24(4): 489 doi: 10.4103/njcp.njcp_242_20
|
110 |
Ji Jang, Tae-Jin Lee, Eon-Gi Sung, In-Hwan Song, Joo-Young Kim. Dapagliflozin induces apoptosis by downregulating cFILPL and increasing cFILPS instability in Caki‑1 cells. Oncology Letters 2022; 24(5) doi: 10.3892/ol.2022.13521
|
111 |
Tie Sun, Jing Tang, Yi-Cong Pan, Chen-Yu Yu, Biao Li, Li-Juan Zhang, Hui-Ye Shu, Qian-Min Ge, Yi Shao. Serum markers change for intraocular metastasis in renal cell carcinoma. Bioscience Reports 2021; 41(9) doi: 10.1042/BSR20203116
|
112 |
JIAFU FENG, BEI XU, CHUNMEI DAI, YAODONG WANG, GANG XIE, WENYU YANG, BIN ZHANG, XIAOHAN LI, JUN WANG. Macrophage-derived exosomal miR-342-3p promotes the progression of renal cell carcinoma through the NEDD4L/CEP55 axis. Oncology Research 2021; 29(5): 331 doi: 10.32604/or.2022.03554
|